http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002040018-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 2001-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c6cefc120ac0e54941c9710d6f30738 |
| publicationDate | 2002-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002040018-A1 |
| titleOfInvention | Subtype selective melatonergics |
| abstract | The invention relates to the use of MT 2 selective melatonergics as anticonvulsant agents and as analgesic agents. More specifically, the invention relates to the use of 6H-isoindolo[2,1-a]indoles or 5,6-dihydroindolo[2,1-a]isoquinolines as described herein which have melatonin agonist activity and which are selective for the MT 2 receptor as anticonvulsant agents or analgesic agents. The invention further relates to the use of 5,6-dihydroindolo[2,1-a]isoquinolines and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles as described herein which have melatonin antagonist activity and which are selective for the MT 2 receptor as pharmacological tools for delineation of physiological responses governed by MT 2 receptor activation either by melatonin or selective agonists disclosed herein and for treatment of disorders associated with overproduction of melatonin such as seasonal affective disorder (SAD) and shift work syndrome. Such melatonin antagonists are also useful for treating Parkinson's Disease. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016077654-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10555919-B2 |
| priorityDate | 2000-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 248.